E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
ACAD holding history
Acadia Pharmaceuticals Inc in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings
- Shares (Q2 2026)
- 15,546
- Value
- $393.3K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 15,546 | $393.3K | <0.1% | −7,291−31.9% | Reduced | Holders |
| Q1 2026 | 22,837 | $508.4K | <0.1% | – | No prior filing | Holders |
| Q3 2025 | – | – | – | – | Not filed | Holders |
| Q2 2025 | 14,035 | $302.7K | <0.1% | −4,683−25.0% | Reduced | Holders |
| Q1 2025 | 18,718 | $310.9K | <0.1% | +8,090+76.1% | Added | Holders |
| Q4 2024 | 10,628 | $195.0K | <0.1% | −7,704−42.0% | Reduced | Holders |
| Q3 2024 | 18,332 | $281.9K | <0.1% | −196−1.1% | Reduced | Holders |
| Q2 2024 | 18,528 | $301.1K | <0.1% | +40+0.2% | Added | Holders |
| Q1 2024 | 18,488 | $341.8K | <0.1% | −4,405−19.2% | Reduced | Holders |
| Q4 2023 | 22,893 | $716.8K | <0.1% | +5,605+32.4% | Added | Holders |
| Q3 2023 | 17,288 | $360.0K | <0.1% | −780−4.3% | Reduced | Holders |
| Q2 2023 | 18,068 | $433.0K | <0.1% | −799−4.2% | Reduced | Holders |
| Q1 2023 | 18,867 | $355.0K | <0.1% | −10,303−35.3% | Reduced | Holders |
| Q4 2022 | 29,170 | $464.0K | <0.1% | +1,763+6.4% | Added | Holders |
| Q3 2022 | 27,407 | $448.0K | <0.1% | +1,786+7.0% | Added | Holders |
| Q2 2022 | 25,621 | $361.0K | <0.1% | +14,048+121.4% | Added | Holders |
| Q1 2022 | 11,573 | $280.0K | <0.1% | +11,573 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −10,673−100.0% | Sold out | Holders |
| Q3 2021 | 10,673 | $177.0K | <0.1% | – | No prior filing | Holders |